Equity Capital Markets

Company · CIK 1808865

iTeos Therapeutics, Inc.

CIK1808865 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressMA
Listedno ticker on SEC record today
First annual or quarterly report2020-09-01

Offerings

2 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-271793
ShelfEffective
 2023-05-102025-09-044
333-239415
IPOFinal prospectus
 2020-06-242020-07-274

Filings

9
FiledFilingRegistrationAccession
2025-09-04EFFECTDeclared effective 333-2717939999999995-25-002827
2024-05-10424B5Shelf takedown 333-2717930001193125-24-136222
2023-05-19EFFECTDeclared effective 333-2717939999999995-23-001480
2023-05-10S-3Shelf registered 333-2717930001193125-23-140056
2020-07-27424B4Final prospectus 333-2394150001193125-20-198657
2020-07-23EFFECTDeclared effective 333-2394159999999995-20-001898
2020-07-20S-1/AAmendment 333-2394150001193125-20-195153
2020-06-24S-1Registration filed 333-2394150001193125-20-177781
2020-05-22DRSDraft made public 377-031860000950123-20-005493

All filings of this company · CSV